Lebrikizumab in Uncontrolled Asthma: Reanalysis in a Well-Defined Type 2 Population.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE(2024)
关键词
Allergic asthma,Lebrikizumab,IL-13,Efficacy,Post hoc analysis,Safety
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要